Lazard Asset Management’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.67M Sell
44,159
-19,546
-31% -$1.06M 0.01% 724
2026
Q1
$2.46M Buy
63,705
+386
+0.6% +$16K ﹤0.01% 807
2025
Q4
$2.94M Buy
63,319
+47,940
+312% +$2.31M 0.01% 725
2025
Q3
$755K Buy
+15,379
New +$804K ﹤0.01% 1232

Other funds holding HNGE

Lazard Asset Management's HNGE Position: Q2 2026 in Review

Lazard Asset Management reduced its Hinge Health (HNGE) stake by 31% in Q2 2026, selling an estimated $1.06M and leaving 44,159 shares worth $3.67M. The position accounts for 0.01% of the portfolio, ranked #724.

Lazard Asset Management first reported a position in HNGE in Q3 2025 and has held it in 4 quarters since. 276 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Lazard Asset Management held 44,159 shares of Hinge Health worth $3.67M as of Q2 2026.
  • Lazard Asset Management sold 19,546 Hinge Health shares in Q2 2026, an estimated $1.06M.
  • Hinge Health made up 0.01% of Lazard Asset Management's portfolio in Q2 2026, its #724 holding.
  • Lazard Asset Management first reported a position in Hinge Health in Q3 2025 and has held it in 4 quarters since.
  • 276 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.